Skip to main content
. 2020 Oct 19;15(10):e0240309. doi: 10.1371/journal.pone.0240309

Table 4. Severe acute respiratory infection incidence rates, by participating site and age group.

  18–49 years old 50–64 years old 65+ years old All Adults
Case Person-years Rate per 100,000 (LCL-UCL) Case Person-years Rate per 100,000 (LCL-UCL) Case Person-years Rate per 100,000 (LCL-UCL) Case Person-years Rate per 100,000 (LCL-UCL)
Bangladesha 226 2,441,487 9 (5–18) 132 420,740 31 (22–45) 116 218,507 53 (41–69) 474 3,080,734 15 (9–25)
China 414 1,129,980 37 (27–51) 78 202,596 39 (28–53) 45 85,225 53 (40–69) 537 1,417,801 38 (28–52)
Egypt1 271 102,251 265 (235–299) 170 24,069 706 (656–760) 51 6,542 780 (727–836) 492 132,862 370 (334–410)
Guatemalab 65 567,486 11 (6–20) 41 105,132 39 (28–53) 62 71,172 87 (71–107) 168 743,790 23 (15–34)
Kenyac 48 16,143 297 (265–333) 20 3,327 601 (555–651) 18 2,906 620 (573–670) 86 22,376 384 (348–425)
Thailandd 112 236,434 47(36–63) 135 73,343 184 (159–213) 215 37,879 568 (523–616) 462 347,656 133 (112–158)

a In Bangladesh and Egypt, population data was available only for 20–49 years of age and rates were calculated using SARI Patient patients 20 and older.

b Restricted to Santa Rose and Quetzaltenango study sites.

c SARI Patients and population data restricted to Karemo region for Siaya District Hospital and population based infectious disease surveillance area for Lwak Mission Hospital.

d Thailand incidence calculations included SARI patients that were eligible for study enrollment but did not consent for study participation.